| Literature DB >> 26283947 |
Vaughn R Steele1, Eric D Claus1, Eyal Aharoni2, Gina M Vincent3, Vince D Calhoun4, Kent A Kiehl5.
Abstract
Rearrest has been predicted by hemodynamic activity in the anterior cingulate cortex (ACC) during error-processing (Aharoni et al., 2013). Here, we evaluate the predictive power after adding an additional imaging modality in a subsample of 45 incarcerated males from Aharoni et al. (2013). Event-related potentials (ERPs) and hemodynamic activity were collected during a Go/NoGo response inhibition task. Neural measures of error-processing were obtained from the ACC and two ERP components, the error-related negativity (ERN/Ne) and the error positivity (Pe). Measures from the Pe and ACC differentiated individuals who were and were not subsequently rearrested. Cox regression, logistic regression, and support vector machine (SVM) neuroprediction models were calculated. Each of these models proved successful in predicting rearrest and SVM provided the strongest results. Multimodal neuroprediction SVM models with out of sample cross-validating accurately predicted rearrest (83.33%). Offenders with increased Pe amplitude and decreased ACC activation, suggesting abnormal error-processing, were at greatest risk of rearrest.Entities:
Keywords: error-processing; event-related potentials; functional magnetic resonance imaging; neuroprediction; recidivism
Year: 2015 PMID: 26283947 PMCID: PMC4522570 DOI: 10.3389/fnhum.2015.00425
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Descriptive statistics and independent samples t-tests for variables used as covariates.
| All participants ( | Rearrested group ( | Not-rearrested group ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Mean | SD | Mean | SD | Mean | SD | ||||||
| Age at release | 45 | 33.69 | 8.08 | 24 | 31.58 | 7.32 | 21 | 36.10 | 8.40 | 1.93 | 43 | 0.061 |
| PCL-R-F1 | 42 | 7.64 | 3.26 | 22 | 7.55 | 3.49 | 20 | 7.74 | 3.07 | 0.18 | 40 | 0.853 |
| PCL-R-F2 | 42 | 14.31 | 3.79 | 22 | 15.17 | 3.39 | 20 | 13.36 | 4.05 | 1.69 | 40 | 0.099 |
| Drug abuse/dependence (Lifetime) | 44 | 2.89 | 1.30 | 23 | 2.91 | 1.28 | 21 | 2.86 | 1.35 | -0.14 | 42 | 0.888 |
| Alcohol abuse/dependence (Lifetime) | 44 | 2.27 | 0.85 | 23 | 2.22 | 0.85 | 21 | 2.33 | 0.86 | 0.45 | 42 | 0.655 |
| NoGo accuracy (ERP) | 45 | 77% | 0.13 | 24 | 74% | 0.15 | 21 | 80% | 0.10 | 1.58 | 43 | 0.123 |
| NoGo accuracy (fMRI) | 45 | 74% | 0.14 | 24 | 70% | 0.15 | 21 | 78% | 0.11 | 1.86 | 43 | 0.069 |
Summary of linear regression analysis of principal components predicting windowed time-domain (TD) components (N = 45).
| Predictors | SE | β | ||
|---|---|---|---|---|
| DV ERN/Ne mean | ||||
| PC1 mean | 12.806 | 4.384 | 0.538∗ | |
| PC2 mean | -2.547 | 3.612 | -0.219 | |
| PC3 mean | -0.423 | 2.904 | -0.041 | |
| PC4 mean | 4.458 | 2.569 | 0.306∧ | |
| PC5 mean | 1.595 | 2.815 | 0.125 | |
| DV Pe mean | ||||
| PC1 mean | 7.442 | 6.166 | 0.136 | |
| PC2 mean | 4.075 | 3.630 | 0.218 | |
| PC3 mean | 4.326 | 2.791 | 0.291 | |
| PC4 mean | 10.300 | 2.846 | 0.474∗ | |
| PC5 mean | -2.684 | 3.725 | -0.103 |
Zero-order Cox and logistic regressions with ERN/Ne, Pe, PC1, PC4, and ACC activation predicting rearrest (N = 45).
| (A) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model | -2 Log likelihood | Overall | Change from previous | |||||
| χ2 | df | Δχ2 | df | |||||
| 160.35 | 0.28 | 1 | 0.597 | 0.29 | 1 | 0.588 | ||
| 155.81 | 4.88 | 1 | 0.027∗ | 4.83 | 1 | 0.028∗ | ||
| 159.94 | 0.67 | 1 | 0.413 | 0.71 | 1 | 0.400 | ||
| 154.06 | 6.55 | 1 | 0.010∗ | 6.59 | 1 | 0.010∗ | ||
| 158.75 | 1.97 | 1 | 0.161 | 1.90 | 1 | 0.169 | ||
| - | ||||||||
| 0.07 | 0.07 | 0.363 | 1.07 | 0.93–1.23 | 59.87 (0.32) | 0.02 (<0.001) | 0.02 (0.001) | |
| 0.15 | 0.06 | 0.022∗ | 1.16 | 1.02–1.31 | 53.84 (0.95) | 0.14 (0.003) | 0.19 (0.005) | |
| -0.62 | 1.68 | 0.702 | 0.57 | 0.02–16.09 | 60.61 (0.18) | 0.002 (0.002) | 0.003 (0.003) | |
| 4.22 | 1.61 | 0.009∗ | 82.45 | 3.05–2712.0 | 50.77 (1.30) | 0.20 (0.006) | 0.27 (0.008) | |
| -0.54 | 0.38 | 0.157 | 0.58 | 0.28–1.22 | 58.56 (0.50) | 0.05 (0.001) | 0.06 (0.002) | |
Cox regression combining ERP or fMRI measures with covariates predicting rearrest (N = 45).
| (A) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Predictor | SE | exp[B] | CI (95%) for exp[B] | |||||
| Age at release | -0.05 | -0.05 | 0.04 | 0.05 | 0.195 | 0.95 | 0.89–1.03 | 0.86–1.03 |
| PCL-R factor 1 | -0.26 | -0.26 | 0.11 | 0.14 | 0.022∗ | 0.77 | 0.62–0.96 | 0.54–0.93 |
| PCL-R factor 2 | -1.37 | -1.37 | 0.46 | 0.56 | 0.003∗ | 0.25 | 0.10–0.62 | 0.05–0.49 |
| Drug | 0.20 | 0.20 | 0.24 | 0.27 | 0.404 | 1.22 | 0.76–1.96 | 0.76–2.24 |
| Alcohol | -0.31 | -0.31 | 0.29 | 0.40 | 0.281 | 0.73 | 0.41–1.29 | 0.29–1.46 |
| ERN/Ne | 0.01 | 0.01 | 0.06 | 0.09 | 0.931 | 1.01 | 0.89–1.14 | 0.86–1.21 |
| Pe | 0.09 | 0.09 | 0.04 | 0.06 | 0.024∗ | 1.10 | 1.01–1.19 | 1.02–1.27 |
| Age at release | -0.05 | -0.05 | 0.04 | 0.05 | 0.137 | 0.95 | 0.88–1.02 | 0.85–1.02 |
| PCL-R factor 1 | -0.27 | -0.27 | 0.11 | 0.14 | 0.013∗ | 0.76 | 0.62–0.95 | 0.53–0.91 |
| PCL-R factor 2 | -1.58 | -1.58 | 0.49 | 0.63 | 0.001∗ | 0.20 | 0.08–0.54 | 0.03–0.39 |
| Drug | 0.10 | 0.10 | 0.24 | 0.28 | 0.683 | 1.10 | 0.69–1.75 | 0.64–1.99 |
| Alcohol | -0.34 | -0.34 | 0.28 | 0.40 | 0.230 | 0.71 | 0.41–1.24 | 0.28–1.36 |
| PC1 | -0.85 | -0.85 | 1.50 | 1.96 | 0.571 | 0.43 | 0.02–8.07 | 0.01–10.98 |
| PC4 | 2.29 | 2.29 | 0.80 | 1.29 | 0.004∗ | 9.84 | 2.04–47.48 | 2.17–334.95 |
| Age at release | -0.07 | -0.07 | 0.04 | 0.04 | 0.034∗ | 0.93 | 0.87–0.99 | 0.83–0.99 |
| PCL-R factor 1 | -0.16 | -0.16 | 0.11 | 0.13 | 0.147 | 0.85 | 0.69–1.06 | 0.63–1.04 |
| PCL-R factor 2 | -0.93 | -1.93 | 0.45 | 0.50 | 0.039∗ | 0.39 | 0.16–0.95 | 0.11–0.80 |
| Drug | 0.20 | 0.20 | 0.21 | 0.26 | 0.352 | 1.22 | 0.80–1.86 | 0.76–2.14 |
| Alcohol | -0.14 | -0.14 | 0.30 | 0.40 | 0.633 | 0.87 | 0.49–1.55 | 0.38–1.89 |
| ACC | -0.53 | -0.53 | 0.29 | 0.41 | 0.066∧ | 0.59 | 0.34–1.04 | 0.22–1.12 |
Cox regression with ERP, fMRI, and covariates predicting rearrest (N = 45).
| (A) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Predictor | SE | exp[B] | CI (95%) for exp[B] | |||||
| Age at release | -0.06 | -0.06 | 0.04 | 0.05 | 0.118 | 0.94 | 0.87–1.02 | 0.82–1.01 |
| PCL-R factor 1 | -0.21 | -0.21 | 0.12 | 0.15 | 0.080∧ | 0.85 | 0.63–0.1.03 | 0.55–1.01 |
| PCL-R factor 2 | -1.23 | -1.23 | 0.48 | 0.60 | 0.011∗ | 0.29 | 0.11–0.75 | 0.06–0.58 |
| Drug | 0.18 | 0.18 | 0.25 | 0.29 | 0.440 | 1.20 | 0.76–1.91 | 0.70–1.82 |
| Alcohol | -0.22 | -0.22 | 0.31 | 0.45 | 0.484 | 0.81 | 0.44–1.48 | 0.31–1.92 |
| ERN/Ne | 0.01 | 0.01 | 0.07 | 0.09 | 0.860 | 1.01 | 0.89–1.15 | 0.86–1.23 |
| Pe | 0.08 | 0.08 | 0.04 | 0.06 | 0.063∧ | 1.08 | 1.00–1.18 | 0.99–1.26 |
| ACC | -0.30 | -0.30 | 0.31 | 0.46 | 0.334 | 0.74 | 0.40–1.37 | 0.26–1.58 |
| Age at release | -0.06 | -0.06 | 0.04 | 0.05 | 0.137 | 0.94 | 0.87–1.02 | 0.84–1.02 |
| PCL-R factor 1 | -0.25 | -0.25 | 0.12 | 0.16 | 0.013∗ | 0.78 | 0.61–0.98 | 0.51–0.96 |
| PCL-R factor 2 | -1.53 | -1.53 | 0.52 | 0.70 | 0.001∗ | 0.22 | 0.08–0.60 | 0.03–0.44 |
| Drug | 0.10 | 0.10 | 0.22 | 0.30 | 0.683 | 1.10 | 0.70–1.74 | 0.64–2.04 |
| Alcohol | -0.30 | -0.30 | 0.31 | 0.45 | 0.230 | 0.74 | 0.40–1.36 | 0.27–1.57 |
| PC1 | -1.00 | -1.00 | 1.57 | 2.08 | 0.571 | 0.37 | 0.02–7.99 | 0.003–10.54 |
| PC4 | 2.10 | 2.10 | 0.98 | 1.42 | 0.004∗ | 8.13 | 1.19–55.36 | 1.32–336.17 |
| ACC | -0.12 | -0.12 | 0.37 | 0.51 | 0.066∧ | 0.89 | 0.43–1.83 | 0.31–2.33 |
| ERN/Ne | -0.01 | 0.01 | 0.05 | 0.06 | 0.843 | 0.99 | 0.89–1.10 | 0.87–1.13 |
| Pe | 0.68 | 0.68 | 0.03 | 0.04 | 0.031∗ | 1.08 | 1.01–1.14 | 1.00–1.17 |
| ACC | -0.27 | -0.27 | 0.21 | 0.27 | 0.200 | 0.76 | 0.50–1.16 | 0.43–1.25 |
| PC1 | -0.63 | -0.63 | 1.17 | 1.39 | 0.591 | 0.53 | 0.05–5.28 | 0.03–7.48 |
| PC4 | 1.46 | 1.46 | 0.70 | 0.91 | 0.039∗ | 4.29 | 1.08–17.04 | 0.91–32.30 |
| ACC | -0.18 | -0.18 | 0.23 | 0.27 | 0.421 | 0.83 | 0.54–1.30 | 0.47–1.40 |
Logistic regressions combining ERP and fMRI with covariates predicting rearrest (N = 45).
| (A) | |||||
|---|---|---|---|---|---|
| Predictor | SE | exp[B] | CI (95%) for exp[B] | ||
| Age at release | -0.02 | 0.06 | 0.762 | 0.98 | 0.88–1.10 |
| PCL-R factor 1 | -0.24 | 0.16 | 0.147 | 0.79 | 0.57–1.08 |
| PCL-R factor 2 | -1.67 | 0.84 | 0.048∗ | 0.19 | 0.04–0.98 |
| Drug | 0.07 | 0.37 | 0.819 | 1.08 | 0.52–2.25 |
| Alcohol | -0.48 | 0.53 | 0.373 | 0.62 | 0.22–1.76 |
| ERN/Ne | -0.0006 | 0.10 | 0.895 | 1.00 | 0.82–1.22 |
| Pe | 0.17 | 0.09 | 0.050∗ | 1.18 | 1.00–1.40 |
| Age at release | -0.03 | 0.06 | 0.600 | 0.97 | 0.86–1.09 |
| PCL-R factor 1 | -0.24 | 0.18 | 0.165 | 0.78 | 0.56–1.10 |
| PCL-R factor 2 | -2.26 | 0.97 | 0.020∗ | 0.11 | 0.02–0.69 |
| Drug | 0.07 | 0.39 | 0.834 | 1.08 | 0.50–2.35 |
| Alcohol | -0.71 | 0.59 | 0.235 | 0.50 | 0.16–1.56 |
| PC1 | -0.26 | 2.49 | 0.877 | 1.57 | 0.01–339.98 |
| PC4 | 6.23 | 2.38 | 0.009∗ | 1712.50 | 5.28–2015200 |
| Age at release | -0.09 | 0.05 | 0.105 | 0.92 | 0.82–1.02 |
| PCL-R factor 1 | -0.06 | 0.16 | 0.706 | 0.94 | 0.69–1.28 |
| PCL-R factor 2 | -0.91 | 0.64 | 0.162 | 0.40 | 0.12–1.42 |
| Drug | 0.02 | 0.36 | 0.886 | 1.02 | 0.50–2.08 |
| Alcohol | -0.07 | 0.51 | 0.851 | 0.94 | 0.35–2.54 |
| ACC | -0.98 | 0.58 | 0.093∧ | 0.38 | 0.12–1.17 |
Logistic regressions combining ERP, fMRI, and covariates predicting rearrest (N = 45).
| (A) | |||||
|---|---|---|---|---|---|
| Predictor | SE | exp[B] | CI (95%) for exp[B] | ||
| Age at release | -0.04 | 0.06 | 0.565 | 0.97 | 0.85–1.09 |
| PCL-R factor 1 | -0.16 | 0.17 | 0.376 | 0.85 | 0.61–1.20 |
| PCL-R factor 2 | -1.58 | 0.86 | 0.069∧ | 0.21 | 0.04–1.11 |
| Drug | -0.02 | 0.40 | 0.882 | 0.99 | 0.45–2.17 |
| Alcohol | -0.28 | 0.57 | 0.613 | 0.76 | 0.25–2.36 |
| ERN/Ne | -0.02 | 0.10 | 0.841 | 0.98 | 0.80–1.21 |
| Pe | 0.16 | 0.09 | 0.076∧ | 1.18 | 0.99–1.41 |
| ACC | -0.75 | 0.62 | 0.235 | 0.48 | 0.14–1.60 |
| Age at release | -0.05 | 0.06 | 0.495 | 0.96 | 0.84–1.09 |
| PCL-R factor 1 | -0.18 | 0.20 | 0.366 | 0.84 | 0.57–1.23 |
| PCL-R factor 2 | -2.17 | 0.99 | 0.028∗ | 0.12 | 0.02–0.79 |
| Drug | 0.01 | 0.41 | 0.902 | 1.01 | 0.45–2.28 |
| Alcohol | -0.57 | 0.61 | 0.357 | 0.57 | 0.17–1.87 |
| PC1 | 0.09 | 2.58 | 0.905 | 1.34 | 0.01–369.55 |
| PC4 | 5.97 | 2.43 | 0.015∗ | 1625 | 3.77–2668700 |
| ACC | -0.53 | 0.74 | 0.478 | 0.59 | 0.15–2.50 |
| ERN/Ne | 0.008 | 0.09 | 0.880 | 1.01 | 0.84–1.21 |
| Pe | 0.13 | 0.07 | 0.055∧ | 1.14 | 1.00–1.30 |
| ACC | -0.61 | 0.45 | 0.183 | 0.54 | 0.23–1.32 |
| PC1 | -0.22 | 1.96 | 0.866 | 0.98 | 0.02–78.58 |
| PC4 | 2.40 | 1.62 | 0.038∗ | 38.31 | 1.32–1436.42 |
| ACC | -0.47 | 0.45 | 0.306 | 0.63 | 0.26–1.52 |
Support vector machine analyses with ERP, fMRI, and covariates predicting rearrest.
| (A) | ||||||
|---|---|---|---|---|---|---|
| Covariates | Time-domain measures | PCA measures | Covariates with TD Measures | Covariates with PCA measures | ||
| Overall classification rate | 60.98% | 65.85% | 70.73% | 73.17% | 70.73% | |
| Specificity | 70.83% | 95.83% | 58.33% | 83.33% | 66.67% | |
| Sensitivity | 47.06% | 23.53% | 88.24% | 58.82% | 76.47% | |
| Positive predictive value | 53.33% | 80.00% | 60.00% | 71.43% | 61.90% | |
| Negative predictive value | 65.38% | 63.89% | 87.50% | 74.07% | 80.00% | |
| Overall classification rate | 68.29% | 63.41% | 70.73% | 78.05% | 68.29% | 73.17% |
| Specificity | 62.50% | 58.33% | 66.67% | 83.33% | 66.67% | 66.67% |
| Sensitivity | 76.47% | 70.59% | 76.47% | 70.59% | 70.59% | 82.35% |
| Positive predictive value | 59.09% | 54.55% | 61.90% | 75.00% | 60.00% | 63.64% |
| Negative predictive value | 78.95% | 73.68% | 80.00% | 80.00% | 76.19% | 84.21% |